Not Rated
|
Fund Size
(0.02% of Investment in Category)
|
Expense Ratio
(2.12% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 17-Oct-25 | 9943.50 | -0.57% | - | 0.23% | 210/236 |
| 1 Month | 24-Sep-25 | 10150.50 | 1.51% | - | 1.33% | 101/236 |
| 3 Month | 24-Jul-25 | 9974.90 | -0.25% | - | 1.74% | 184/233 |
| 6 Month | 24-Apr-25 | 10430.70 | 4.31% | - | 8.43% | 184/223 |
| YTD | 01-Jan-25 | 9789.20 | -2.11% | - | 3.96% | 169/212 |
| 1 Year | 24-Oct-24 | 10060.70 | 0.61% | 0.61% | 3.53% | 132/195 |
| 2 Year | 23-Oct-23 | 16123.00 | 61.23% | 26.89% | 20.71% | 19/151 |
| 3 Year | 21-Oct-22 | 17322.80 | 73.23% | 20.02% | 19.73% | 54/126 |
| 5 Year | 23-Oct-20 | 19429.00 | 94.29% | 14.19% | 22.12% | 95/103 |
| Since Inception | 28-Feb-19 | 29881.80 | 198.82% | 17.87% | 12.70% | 59/216 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 24-Oct-24 | 12000 | 12385.33 | 3.21 % | 5.99 % |
| 2 Year | 23-Oct-23 | 24000 | 27669.76 | 15.29 % | 14.32 % |
| 3 Year | 21-Oct-22 | 36000 | 48663.58 | 35.18 % | 20.56 % |
| 5 Year | 23-Oct-20 | 60000 | 90000.77 | 50 % | 16.21 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 85.9 | 10.08% | 0.35% | 10.73% (May 2025) | 9.72% (Aug 2025) | 53.85 k | 0.00 |
| Apollo Hospitals Enterprises Ltd. | Hospital | 49.8 | 5.85% | 0.05% | 5.85% (Sep 2025) | 2.91% (Nov 2024) | 6.72 k | 0.00 |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 47.3 | 5.55% | 0.26% | 5.55% (Sep 2025) | 4.91% (Oct 2024) | 13.13 k | 0.00 |
| Cipla Ltd. | Pharmaceuticals | 46.9 | 5.51% | -0.11% | 5.62% (Aug 2025) | 4.19% (Nov 2024) | 31.22 k | 0.00 |
| Fortis Healthcare Ltd. | Hospital | 40.8 | 4.79% | 0.45% | 4.79% (Sep 2025) | 0% (Oct 2024) | 42.10 k | 0.00 |
| Piramal Pharma Ltd. | Pharmaceuticals | 37.9 | 4.45% | 0.33% | 7.55% (Oct 2024) | 3.73% (Jul 2025) | 1.98 L | 0.00 |
| Neuland Laboratories Ltd. | Pharmaceuticals | 35.3 | 4.14% | 0.46% | 4.24% (Nov 2024) | 3.11% (Apr 2025) | 2.41 k | 0.00 |
| Divis Laboratories Ltd. | Pharmaceuticals | 35 | 4.11% | -0.16% | 4.84% (May 2025) | 3.92% (Dec 2024) | 6.16 k | 0.00 |
| Aurobindo Pharma Ltd. | Pharmaceuticals | 33.9 | 3.98% | 0.34% | 4.57% (Apr 2025) | 0% (Oct 2024) | 31.30 k | 0.00 |
| Alkem Laboratories Ltd. | Pharmaceuticals | 33.7 | 3.96% | 0.22% | 3.96% (Sep 2025) | 3.36% (Nov 2024) | 6.21 k | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 2.77% |
| Net Receivables | Net Receivables | -0.60% |
Ratios calculated on daily returns for last 3 years (Updated as on 30th September, 2025)
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Regular Plan - Growth | NA | 406.67 | 6.30 | 27.21 | 76.60 | 42.54 | 42.43 |
| Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth | NA | 266.19 | 1.98 | 7.83 | 23.75 | 28.77 | 18.13 |
| Nippon India Japan Equity Fund - Growth | NA | 289.73 | 1.47 | 6.87 | 17.30 | 23.19 | 18.80 |
| Quant BFSI Fund - Regular Plan - Growth | NA | 655.17 | 6.25 | 5.80 | 22.74 | 21.90 | 0.00 |
| HDFC Transportation and Logistics Fund - Regular Plan - Growth | NA | 1651.55 | 1.28 | 11.98 | 29.85 | 20.30 | 0.00 |
| DSP Banking & Financial Services Fund - Regular Plan - Growth | NA | 1419.62 | 6.27 | 5.61 | 10.60 | 19.80 | 0.00 |
| Franklin Asian Equity Fund - Growth | NA | 279.13 | 3.20 | 9.31 | 25.62 | 18.65 | 17.18 |
| Motilal Oswal Business Cycle Fund - Regular Plan - Growth | NA | 1984.52 | 7.26 | 6.88 | 14.58 | 18.34 | 0.00 |
| SBI Banking & Financial Services Fund - Regular Plan - Growth | NA | 8693.07 | 5.74 | 4.45 | 11.18 | 18.26 | 19.01 |
| ITI Banking and Financial Services Fund - Regular Plan - Growth | NA | 311.03 | 7.54 | 4.83 | 8.29 | 16.62 | 13.95 |
Out of 45 mutual fund schemes offered by this AMC, 2 is/are ranked 4 * , 10 is/are ranked 3 * , 11 is/are ranked 2 * , 4 is/are ranked 1 * , and 18 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| LIC MF Liquid Fund - Regular Plan - Growth | 2 | 11402.57 | 0.47 | 1.40 | 2.95 | 6.63 | 6.96 |
| LIC MF Money Market Fund - Regular Plan - Growth | NA | 3130.05 | 0.50 | 1.44 | 3.28 | 6.73 | 6.37 |
| LIC MF Large & Mid Cap Fund - Growth | 3 | 3046.84 | 1.55 | 0.40 | 6.63 | 1.98 | 16.72 |
| LIC MF Nifty 8-13 yr G-Sec ETF | NA | 2248.29 | 0.32 | 0.23 | 1.39 | 8.07 | 8.83 |
| LIC MF Nifty 8-13 yr G-Sec ETF | NA | 2248.29 | 0.33 | 0.28 | 1.46 | 8.24 | 9.06 |
| LIC MF Banking & PSU Fund - Growth | 3 | 1909.36 | 0.76 | 1.06 | 2.85 | 7.93 | 7.49 |
| LIC MF Multi Cap Fund - Regular Plan - Growth | NA | 1715.77 | 2.24 | 1.65 | 10.75 | 6.02 | 0.00 |
| LIC MF Low Duration Fund - Growth | 3 | 1705.18 | 0.51 | 1.35 | 3.10 | 7.14 | 6.91 |
| LIC MF Low Duration Fund - Growth | 3 | 1705.18 | 0.53 | 1.44 | 3.32 | 7.53 | 7.53 |
| LIC MF Large Cap Fund - Growth | 2 | 1445.32 | 2.27 | 1.72 | 5.02 | 4.30 | 12.58 |